The Cancer News(@BTFCancerNews) 's Twitter Profileg
The Cancer News

@BTFCancerNews

Authoritative Resource for Everything About Cancer

The Cancer News features independent and expert analysis in the field of hematology and oncology.

ID:1600276684384927744

linkhttps://cancernewsglobal.com calendar_today06-12-2022 23:51:24

309 Tweets

150 Followers

83 Following

Follow People
The Cancer News(@BTFCancerNews) 's Twitter Profile Photo

FDA Approves Osimertinib Plus Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer with EGFR Mutation - read more ⬇️
by Anish K. Shah

thecancernews.org/fda-approves-o…
approval news care

account_circle
The Cancer News(@BTFCancerNews) 's Twitter Profile Photo

Read more on the FDA Grants Accelerated Approval to Lifileucel for Previously Treated Metastatic Melanoma here ⬇️
by Anish K. Shah

thecancernews.org/fda-grants-acc…
approval news care

account_circle
The Cancer News(@BTFCancerNews) 's Twitter Profile Photo

FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Skipping Alterations - learn more ⬇️
by Anish K. Shah

thecancernews.org/fda-approves-t…
approval news care

account_circle
The Cancer News(@BTFCancerNews) 's Twitter Profile Photo

FDA approves eflornithine for high-risk neuroblastoma following partial response to prior therapy - full article here ⬇️
by Anish K. Shah

thecancernews.org/fda-approves-e…
approval news care

account_circle
The Cancer News(@BTFCancerNews) 's Twitter Profile Photo

Read about the FDA approval of Enfortumab And Pembrolizumab For Urothelial Cancer In An Advanced Or Metastatic Stage here ⬇️
by Anish K. Shah

thecancernews.org/fda-approves-e…
approval news care

account_circle
The Cancer News(@BTFCancerNews) 's Twitter Profile Photo

Recent FDA approval of Belzutifan For Advanced Renal Cell Carcinoma With Prior Therapy - read more ⬇️
by Anish K. Shah

thecancernews.org/fda-approves-b…
approval news care

account_circle
Binaytara Foundation(@btfoundation) 's Twitter Profile Photo

🚨 3 Days Left! 🚨

The deadline for abstract submissions is quickly approaching!

Don't miss the opportunity to present at our highly anticipated Summit on Cancer Health Disparities.

Learn more: education.binayfoundation.org/abstracts-2024

🚨 3 Days Left! 🚨 The deadline for #SCHD24 abstract submissions is quickly approaching! Don't miss the opportunity to present at our highly anticipated Summit on Cancer Health Disparities. Learn more: education.binayfoundation.org/abstracts-2024 #AbstractSubmission #CME #cancercare…
account_circle
Binaytara Foundation(@btfoundation) 's Twitter Profile Photo

🌟 Don't miss our annual gala! Join us for live entertainment, live & silent auctions, dining, learning, friendship, and more.
🗓️ April 27th, 2024
🎟️ Purchase tickets: binayfoundation.ejoinme.org/2024tickets

care

account_circle
The Cancer News(@BTFCancerNews) 's Twitter Profile Photo

FDA approves eflornithine for high-risk neuroblastoma following partial response to prior therapy. Read more here ⬇️
by Anish K. Shah

thecancernews.org/fda-approves-e…
approval news

account_circle
The Cancer News(@BTFCancerNews) 's Twitter Profile Photo

Read here about the latest FDA approval of Enfortumab and Pembrolizumab for Urothelial Cancer in an advanced or metastatic stage ⬇️
by Anish K. Shah

thecancernews.org/fda-approves-e…

approval news

account_circle
The Cancer News(@BTFCancerNews) 's Twitter Profile Photo

For Updates from clinical trials from two HR+ breast cancers with neoadjuvant immune checkpoint inhibition, read here ⬇️
by Shipra Gandhi

thecancernews.org/updates-from-c…

account_circle
The Cancer News(@BTFCancerNews) 's Twitter Profile Photo

For more information on the approval of Nirogacestat for Adult Patients with Progressing Desmoid Tumors, read here ⬇️
by Anish K. Shah

thecancernews.org/fda-approves-n…
news approval

account_circle